180 related articles for article (PubMed ID: 23486561)
1. An imaging protocol for dynamic contrast-enhanced breast MRI with 3.0T: using sagittal sequence interleaved between axial sequences.
Park JE; Lee JE; Hwang JY; Cha ES
Acta Radiol; 2013 Jul; 54(6):608-13. PubMed ID: 23486561
[TBL] [Abstract][Full Text] [Related]
2. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
[TBL] [Abstract][Full Text] [Related]
3. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
Gokalp G; Topal U; Yildirim N; Tolunay S
Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
[TBL] [Abstract][Full Text] [Related]
5. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
[TBL] [Abstract][Full Text] [Related]
6. Temporomandibular joint (TMJ) pain revisited with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).
Tasali N; Cubuk R; Aricak M; Ozarar M; Saydam B; Nur H; Tuncbilek N
Eur J Radiol; 2012 Mar; 81(3):603-8. PubMed ID: 21300493
[TBL] [Abstract][Full Text] [Related]
7. [Quantitative assessment of therapy related effects after breast conserving therapy with dynamic MRI of the breast].
Wersebe A; Xydeas T; Clauss T; Dietz K; Belka C; Fersis N; Claussen CD; Müller-Schimpfle M
Rofo; 2001 Dec; 173(12):1109-17. PubMed ID: 11740672
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
9. Breast MRI: intraindividual comparative study at 1.5 and 3.0T; initial experience.
Djilas-Ivanovic DD; Prvulovic NP; Bogdanovic-Stojanovic DD; Ivkovic-Kapicl TV; Ivanovic VM; Golubovic A; Semelka RC
J BUON; 2012; 17(1):65-72. PubMed ID: 22517695
[TBL] [Abstract][Full Text] [Related]
10. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
[TBL] [Abstract][Full Text] [Related]
11. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
Kuhl CK; Schild HH; Morakkabati N
Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
[TBL] [Abstract][Full Text] [Related]
12. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer.
Espinosa LA; Daniel BL; Vidarsson L; Zakhour M; Ikeda DM; Herfkens RJ
Radiology; 2005 Nov; 237(2):429-36. PubMed ID: 16244250
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience.
Kuhl CK; Jost P; Morakkabati N; Zivanovic O; Schild HH; Gieseke J
Radiology; 2006 Jun; 239(3):666-76. PubMed ID: 16549623
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of pancreatic cancer by multiple breath-hold dynamic contrast-enhanced magnetic resonance imaging at 3.0T.
Yao X; Zeng M; Wang H; Sun F; Rao S; Ji Y
Eur J Radiol; 2012 Aug; 81(8):e917-22. PubMed ID: 22695786
[TBL] [Abstract][Full Text] [Related]
15. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
17. High-spatial-resolution 3-T breast MRI of nonmasslike enhancement lesions: an analysis of their features as significant predictors of malignancy.
Uematsu T; Kasami M
AJR Am J Roentgenol; 2012 May; 198(5):1223-30. PubMed ID: 22528918
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
[TBL] [Abstract][Full Text] [Related]
19. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
20. [Comprehensive magnetic resonance imaging for breast cancer].
Meladze NV; Ternovoĭ SK; Sharia MA; Solopova AE
Ter Arkh; 2013; 85(4):29-33. PubMed ID: 23808288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
